Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation

Aes Simões, D. M. Pereira, S. E. Gomes, H. Brito, T. Carvalho, A. French, R. E. Castro, C. J. Steer, S. N. Thibodeau, C. M.P. Rodrigues, P. M. Borralho

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology